Merit Medical (MMSI) has disclosed a new risk, in the Corporate Activity and Growth category.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Merit Medical faces a potential business risk as none of its directors or officers reported any adoption or termination of trading arrangements under Rule 10b5-1 or non-Rule 10b5-1 during the quarter ending September 30, 2025. This lack of disclosure could signal a gap in transparency or strategic planning regarding insider trading activities, which might affect investor confidence. The absence of such arrangements might also indicate a missed opportunity for the company to manage insider transactions in a structured manner. Consequently, stakeholders may view this as a risk factor that could impact the company’s governance and market perception.
Overall, Wall Street has a Strong Buy consensus rating on MMSI stock based on 4 Buys and 1 Hold.
To learn more about Merit Medical’s risk factors, click here.